Incretin based therapies such as GLP-1 receptor agonists have revolutionised management of type 2 diabetes by enhancing insulin secretion, slowing gastric emptying and reducing appetite (Dungan & DeSantis, 2025)
LiuTLiXChenYLiJWangRDingYet al
if you are taking other medicines (insulin, or a drug that stimulates insulin release), dose adjustments may be needed to reduce your risk of hypoglycemia
If youre switching from Wegovy to Saxenda, you should wait a week as you normally would between injections before youre able to start your Saxenda pen
Clinical trials show that patients who discontinue tirzepatide after initial weight loss regain approximately 14% of their body weight over 52 weeks
The most commonly reported adverse effects in these trials were gastrointestinal in nature including nausea, vomiting, diarrhoea, and constipation consistent with the broader class of GLP-1 receptor agonists